Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.
Lefaucheur C, Viglietti D, Hidalgo LG, Ratner LE, Bagnasco SM, Batal I, Aubert O, Orandi BJ, Oppenheimer F, Bestard O, Rigotti P, Reisaeter AV, Kamar N, Lebranchu Y, Duong Van Huyen JP, Bruneval P, Glotz D, Legendre C, Empana JP, Jouven X, Segev DL, Montgomery RA, Zeevi A, Halloran PF, Loupy A. Lefaucheur C, et al. Among authors: reisaeter av. J Am Soc Nephrol. 2018 Feb;29(2):620-635. doi: 10.1681/ASN.2017050589. Epub 2017 Oct 17. J Am Soc Nephrol. 2018. PMID: 29042454 Free PMC article.
Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.
García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV. García-Carro C, et al. Among authors: reisaeter av. Transplantation. 2017 Jun;101(6):1410-1415. doi: 10.1097/TP.0000000000001216. Transplantation. 2017. PMID: 27163535
HLA Mismatch and Allograft Survival.
Mjoen G, Reisaeter AV, Dahle DO. Mjoen G, et al. Among authors: reisaeter av. Transplantation. 2016 Sep;100(9):e52. doi: 10.1097/TP.0000000000001366. Transplantation. 2016. PMID: 27399204 No abstract available.
Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial.
Marks WH, Mamode N, Montgomery RA, Stegall MD, Ratner LE, Cornell LD, Rowshani AT, Colvin RB, Dain B, Boice JA, Glotz D; C10-001 Study Group. Marks WH, et al. Am J Transplant. 2019 Oct;19(10):2876-2888. doi: 10.1111/ajt.15364. Epub 2019 Apr 19. Am J Transplant. 2019. PMID: 30887675 Free PMC article. Clinical Trial.
Timing of Kidney Clamping and Deceased Donor Kidney Transplant Outcomes.
Ville S, Lorent M, Kerleau C, Asberg A, Legendre C, Morelon E, Buron F, Garrigue V, Le Quintrec M, Girerd S, Ladrière M, Albano L, Sicard A, Glotz D, Lefaucheur C, Branchereau J, Jacobi D, Giral M; EKiTE Consortium. Ville S, et al. Clin J Am Soc Nephrol. 2021 Nov;16(11):1704-1714. doi: 10.2215/CJN.03290321. Epub 2021 Oct 8. Clin J Am Soc Nephrol. 2021. PMID: 34625421 Free PMC article.
131 results